Business Description
BCAL Diagnostics Ltd
ISIN : AU0000160921
Share Class Description:
ASX:BDX: Ordinary SharesDescription
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.34 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.27 | |||||
| 9-Day RSI | 26.69 | |||||
| 14-Day RSI | 36.21 | |||||
| 6-1 Month Momentum % | 7.14 | |||||
| 12-1 Month Momentum % | 16.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.21 | |||||
| Quick Ratio | 5.21 | |||||
| Cash Ratio | 4.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -79.71 | |||||
| ROA % | -60.64 | |||||
| ROIC % | -392.86 | |||||
| ROC (Joel Greenblatt) % | -319.08 | |||||
| ROCE % | -97.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.79 | |||||
| Price-to-Tangible-Book | 4.55 | |||||
| EV-to-EBIT | -2.87 | |||||
| EV-to-EBITDA | -2.98 | |||||
| EV-to-FCF | -4.71 | |||||
| Price-to-Net-Current-Asset-Value | 4.55 | |||||
| Price-to-Net-Cash | 9.1 | |||||
| Earnings Yield (Greenblatt) % | -34.83 | |||||
| FCF Yield % | -18.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BCAL Diagnostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.022 | ||
| Beta | 0 | ||
| Volatility % | 47.05 | ||
| 14-Day RSI | 36.21 | ||
| 14-Day ATR (A$) | 0.002858 | ||
| 20-Day SMA (A$) | 0.0982 | ||
| 12-1 Month Momentum % | 16.67 | ||
| 52-Week Range (A$) | 0.07 - 0.21 | ||
| Shares Outstanding (Mil) | 252.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BCAL Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BCAL Diagnostics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
BCAL Diagnostics Ltd Frequently Asked Questions
What is BCAL Diagnostics Ltd(ASX:BDX)'s stock price today?
The current price of ASX:BDX is A$0.09. The 52 week high of ASX:BDX is A$0.21 and 52 week low is A$0.07.
When is next earnings date of BCAL Diagnostics Ltd(ASX:BDX)?
The next earnings date of BCAL Diagnostics Ltd(ASX:BDX) is .
Does BCAL Diagnostics Ltd(ASX:BDX) pay dividends? If so, how much?
BCAL Diagnostics Ltd(ASX:BDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers